Skip to content
Review Open access

AI safety evaluation in an underrepresented population: real-world performance of clinical decision support and frontier language models on Medicaid patient messaging triage

Aug 2026 · BMC Medical Informatics and Decision Making · 0 citations

TL;DR

No evaluated tool or combination was sufficiently accurate to enable physician-unassisted triage in this setting of patient-initiated text messages in a multi-state Medicaid population.

Abstract

Studies of artificial intelligence tools used in patient triage have largely involved academic medical center cohorts, scripted patient-actor scenarios, or knowledge benchmarks. Populations that may rely on such tools due to constrained access to in-person care, including Medicaid patients, have been less fully evaluated. To compare combinations of safety guardrails added to artificial intelligence tools for triage of patient-initiated text messages in a multi-state Medicaid population. Retrospective evaluation of 2000 messages from Medicaid patients across three U.S. states (Virginia, Washington, Ohio) during January 2023 through November 2025. Three physicians independently adjudicated each message under blinded review; disagreements were resolved by majority and a senior-physician arbiter. Tools included a deployed decision support system with a Conservative Q-Learning controller, supervised baselines (XGBoost+sentence-BERT, logistic regression, rule-based guardrails), and frontier large language models (Claude Opus 4.7, GPT-5.5, Gemini 3.1 Pro, each with and without retrieval-augmented generation). Combinations spanned single tools, ensembles, cascades, multi-model consensus rules, and four-component guardrail compositions identified by a structured literature review. Thresholds and Platt calibration were fit on a held-out validation split and frozen before the test pass. Two pre-specified targets: an autonomous (physician-unassisted) triage benchmark of sensitivity and specificity both 0.80 or higher; and a sensitivity-floor target of 0.80 to 0.95 with clinician review of flagged messages. Real-world messages had lower reading level (grade 4.6 versus 5.8) and more colloquialisms (59.1% versus 19.5%) than physician-scripted scenarios. Hazard prevalence on blinded physician review was 8.2% (165 of 2000). Two configurations met the sensitivity-floor target: a high-recall first-stage screen (sensitivity 0.855; 12.0 missed hazards and 729 alerts per 1,000 messages) and a disagreement-stratified clinician-review workflow (sensitivity 0.939; 5.0 missed hazards and 878 alerts per 1,000 messages). No configuration met the autonomous benchmark; sensitivity and specificity reached 0.594 and 0.592 for the best balanced single tool, 0.685 and 0.575 for the best balanced ensemble, and 0.297 and 0.874 for the highest-specificity cascade. No evaluated tool or combination was sufficiently accurate to enable physician-unassisted triage in this setting. Two configurations met the pre-specified sensitivity-floor target under clinician review of flagged messages, following the classical clinical-screening pattern.

Read PDF

Similar papers

Open access Jul 2026

Bedside Triage by Large Language Models in Acute Pancreatitis: A Scenario-Based Comparative Evaluation of GPT-4, GPT-5, and Gemini.

BACKGROUND Early decision-making in acute pancreatitis (AP) involves diagnostic confirmation, early severity triage, escalation thresholds, and initiation of guideline-concordant management under time pressure and incomplete information. Large language models (LLMs) may support structured bedside reasoning, but their clinical usefulness cannot be inferred from guideline knowledge alone. METHODS A cross-sectional, scenario-based comparative evaluation was conducted in January 2026 using 20 AP scenarios: 15 refined hypothetical vignettes and 5 de-identified, privacy-modified real-life case patterns. GPT-4, GPT-5, and Gemini received identical single-turn prompts. Model access was through OpenAI API gpt-4-0613, OpenAI API gpt-5, and Google Vertex AI Gemini 1.0 Pro; temperature was set to 0.0, and each prompt was repeated three times per model. Outputs were scored by two independent clinician-raters using a prespecified 1-5 ordinal rubric across guideline concordance, safety, actionability, and data-synthesis quality. Two senior board-certified surgeons independently generated expert reference pathways for comparison. RESULTS GPT-5 achieved the highest guideline concordance (4.28 ± 0.38) and safety (4.20 ± 0.45) profiles. GPT-4 provided the clearest stepwise actionability (4.15 ± 0.48), whereas Gemini showed the strongest data-synthesis quality (4.22 ± 0.52). With deterministic settings, internal consistency across three repeated runs was 100%. All models demonstrated clinically relevant failure modes, particularly unwarranted certainty under missing data; this occurred in 12/20 GPT-4, 7/20 GPT-5, and 15/20 Gemini outputs. CONCLUSION No model should be used as a stand-alone bedside decision-maker for AP. In this scenario-based early evaluation, GPT-5 was the most safety-aligned model, GPT-4 was the most operationally actionable, and Gemini was strongest for synthesis, but all require clinician oversight, prospective validation, and governance before clinical deployment.

Y. K. Çalışkan, Fatih Başak, Olgun Erdem · 0 citations
Open access Jul 2026

Profile-associated financial and access-related framing in LLM-generated pediatric asthma referral plans: a factorial audit of seven large language models

LLM-generated pediatric asthma referral plans varied in financial-access, geographic-access, navigation, SDOH-recognition, and selected tone-related framing, which support evaluating structural and access-related framing alongside biomedical content in clinical LLM audits.

Zhendong Liu, Xiaoping Yang, Yu Zhang et al. · 0 citations
Jul 2026

When 99.98% is too Good to be True: Preventing Rule-Induced Overfitting in Embodied Clinical AI for Surgical Readmission Prediction

Embodied Artificial Intelligence (AI) systems are increasingly used to support clinical decision-making, telemedicine follow-up, and resource allocation, particularly in remote and resource-constrained healthcare settings. In these deployments, predictive models are embedded within clinical workflows and operate under human oversight, making safety, transparency, and reliability essential for regulatory-compliant use. A key but underexplored factor affecting trustworthiness is how supervision signals are derived from unstructured clinical text. This paper analyses the impact of text-derived label construction on embodied clinical AI for postoperative risk monitoring. Using surgical readmission prediction from free-text clinical notes, we compare two weak supervision strategies: a myopic keyword-based heuristic and a context-aware labeling framework that accounts for negation, temporal scope, and clinical severity. Although the naive approach achieves near-perfect accuracy (up to 99.98%), we show that this performance is driven by rule-induced target leakage, where models learn documentation artifacts rather than clinically meaningful deterioration signals. We propose an auditable, context-aware labeling protocol aligned with the requirements of deployable clinical decision support systems. While trading inflated accuracy for more realistic performance, the proposed approach improves discrimination and patient-level calibration-properties essential for safe human-in-the-loop operation in telemedicine and remote care. These findings highlight that trustworthy embodied AI depends not only on model sophistication, but also on clinically grounded and transparent supervision mechanisms.

Antoine B. Bagula, Landry Mbale, Olasupo O. Ajayi et al. · 0 citations
Open access Jul 2026

AI-enabled clinical decision support in breast cancer care: a blinded multicenter benchmarking study comparing medically specialized with a general-purpose system

Medically specialized AI systems that have obtained regulatory clearance as medical devices can be deployed for patient-specific clinical decision support under defined compliance requirements. However, it remains unclear whether medical specialization and regulatory status translate into higher-quality breast cancer treatment recommendations than those produced by a general-purpose large language model (LLM). This blinded, multicenter study compared the performance of two medically specialized AI systems with a general-purpose model in breast cancer care. Two medically specialized (Prof. Valmed and OpenEvidence) and one general-purpose system (ChatGPT-5 Thinking) were prompted to generate treatment plans for 20 standardized breast cancer patient cases. Outputs were rated and ranked by blinded, board-certified breast cancer specialists from seven university breast cancer centers for safety, guideline adherence, medical adequacy, completeness, overall quality, and logical coherence. Statistical analyses comprised descriptive statistics, inter-rater reliability assessment, non-parametric performance comparisons of rating and ranking outcomes, and correlation analyses. Mean (± standard deviation) processing time for ChatGPT-5 Thinking (159 ± 58 s) was more than fourfold higher than that of Prof. Valmed (35 ± 4) and OpenEvidence (9 ± 1). ChatGPT-5 Thinking achieved significantly higher ratings across all evaluation categories, with no significant differences between the two medically specialized systems. Treatment plans generated by ChatGPT-5 Thinking were ranked as the top choice in 96.4% of rater-case combinations, compared with 3.6% for OpenEvidence, while Prof. Valmed was never ranked first. In this blinded, multicenter evaluation, a general-purpose LLM outperformed two medically specialized, retrieval-augmented systems in generating breast cancer treatment plans across all assessed categories. These results indicate that while regulatory clearance and domain specialization address key requirements for AI-enabled clinical decision support systems, these factors alone do not translate into superior performance in breast cancer care. At present, medically specialized systems may be best used as supportive tools under expert oversight, while further optimization and real-world validation are needed. Clinical trial number: Not applicable

Jonas Freudenberg, J. Knitza, N. Gremke et al. · 0 citations
Open access Jul 2026

Evaluating Large Language Models for AI-Assisted Decision Support in Legal Capacity Assessment: A Comparative Study Using Interdisciplinary Medical Board Recommendations as the Expert Medical Reference Standard

LLMs demonstrated agreement with IMBD recommendations on standardized medico-legal case vignettes, supporting further investigation of their potential role as AI-assisted decision-support tools under expert supervision.

H. Aydoğan, Muhammet Sevindik, Zeynep Unat Öztürk et al. · 0 citations
Review Aug 2026

AI-Powered Prescription Error Detection Using Large Language Models (LLMs): A Systematic Review and Future Perspectives

It is concluded that LLM-based decision-support tools hold substantial promise as complementary — rather than autonomous — decision-support systems capable of transforming medication safety and pharmacy practice.

K. K. Kumar, Koyya Gowtham Reddy, K. Reddy · 0 citations